Brendan graduated with a BSc (Hons) in Pharmacy (1999) and a PhD in Medicinal Chemistry (2004) from Queen’s University Belfast. He was appointed to a Lectureship in Pharmaceutics (Pharmaceutical Microbiology) in July 2004 in the School of Pharmacy at Queen’s. In 2005 he was a visiting researcher in the laboratory of Prof Howard Ceri, University of Calgary, where he remains a visiting scientist in the Biofilm Research Group. He was promoted to Professor of Pharmaceutical Microbiology in 2015. His research aims to elucidate the mechanistic and biochemical pathways central to the process of microbial biofilm formation and to uncover novel targets for prevention of microbial biofilms; spanning microbiology, chemical biology, and synthetic/medicinal chemistry directed toward antimicrobial and anti-biofilm applications. His main interests include the role of proteolytic enzymes in biofilm formation and development of novel approaches for biofilm control in chronic infections. He has an active research interest in antibiotic biodiscovery from marine bacteria and achaea (extreme halophiles). Brendan is the 2013 recipient of the Royal Pharmaceutical Society Science Award for his research contributions in the field of biofilm control and pharmaceutical microbiology. He is an editor of the textbook ‘Hugo & Russell’s Pharmaceutical Microbiology’ (8th Ed) and is responsible for teaching all aspects of pharmaceutical microbiology and infectious diseases to undergraduate pharmacy students at QUB.
Infectious diseases have dictated the length, timbre or trajectory of the terms of many past Presidents of the United States of America.